Iker Alonso González | Medicine and Dentistry | Best Researcher Award

Mr. Iker Alonso González | Medicine and Dentistry | Best Researcher Award 

FACULTATIVO ESPECIALISTA MEDICO-TECNICO EN MICROBIOLOGÍA Y PARASITOLOGÍA at Cruces University Hospital | Spain

Mr. Iker Alonso González is a dedicated researcher and professional in the field of microbiology and clinical parasitology, recognized for his growing contributions to medical and pharmaceutical sciences. He holds a degree in Pharmacy from the University of the Basque Country (UPV/EHU) and has further specialized in Microbiology and Clinical Parasitology at Cruces University Hospital, where he continues to advance his expertise in infectious disease research and diagnostics. His professional experience at Osakidetza the Basque Health Service combines clinical practice with applied research, focusing on microbial resistance, infectious disease control, and antibiotic stewardship. He has presented numerous research communications, including fourteen posters and two oral presentations at the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), addressing critical topics such as antimicrobial resistance patterns in Shigella spp. and the clinical impact of post-treatment uroculture interventions. His scientific publication, “Multiresistant Aeromonas hydrophila bacteremia,” published in Enferm Infecc Microbiol Clin (Engl Ed), reflects his analytical approach and contribution to understanding emerging multidrug-resistant pathogens. His current research interests center around the development of evidence-based antimicrobial protocols, optimization of laboratory diagnostics, and epidemiological monitoring of infectious diseases in clinical settings. Mr. Iker Alonso González’s participation in national research forums and professional societies highlights his commitment to academic collaboration and scientific advancement. His early scholarly impact is reflected in his record of 2 citations by 2 documents, 3 published works, and an h-index of 1, indicating a promising trajectory in medical research. He is also engaged in continuous professional development, ensuring alignment with global standards in clinical microbiology and pharmaceutical practice. Through his rigorous research, clinical application, and scholarly engagement, Mr. Iker Alonso González exemplifies the integration of scientific inquiry and healthcare innovation, contributing to the ongoing efforts to enhance antimicrobial stewardship and patient outcomes in contemporary medicine.

Profile: Scopus

Featured Publications:

  • Alonso-González, I. (2025). Upper limb abscess due to an unusual Clostridium species in an immunocompetent child. Enfermedades Infecciosas y Microbiología Clínica.

  • Alonso-González, I. (2023). Sensitivity profile of Shigella spp. isolates in patients with travelers’ diarrhea in a tertiary hospital in the period 2017–2022. Presented at the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

  • Alonso-González, I. (2023). Impact of a PROA intervention on the request of non-proven post-treatment control urocultures. Presented at the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

  • Alonso-González, I. (2022). Multiresistant Aeromonas hydrophila bacteremia. Enfermedades Infecciosas y Microbiología Clínica

 

Kanchan Bhatia | Biological Sciences | Best Researcher Award

Dr. Kanchan Bhatia | Biological Sciences | Best Researcher Award

 Clinical Assistant Professor at Arizona State University, United States.

🌍Dr. Kanchan Bhatia is a Clinical Assistant Professor at Arizona State University (ASU), specializing in toxicology, neurodegeneration, and cardiovascular research. With a strong academic background (Ph.D. from Jamia Hamdard) and extensive teaching and research experience in India, the USA, and Saudi Arabia, she has contributed significantly to scientific literature with 26 publications in reputed journals. Dr. Bhatia has received numerous awards for her exemplary teaching, research, and leadership, including the SUN Innovation Award (2021) and American Heart Association Postdoctoral Fellowship (2012). Her multidisciplinary expertise and dedication to student success are evident through her innovative teaching practices and impactful research.

Profile👤

Education 🎓

🎓Dr. Bhatia earned her Ph.D. in Toxicology from Jamia Hamdard, New Delhi, India, in 2008. She holds an M.S. in Biotechnology from the same institution and a B.S. in Microbiology from Delhi University. In 2022, she completed a Graduate Certificate in Clinical Trials Design and Management from the University of California, San Diego, enhancing her expertise in clinical research methodologies.🎓

Experience💼

🩺Since August 2020, Dr. Bhatia has served as a Clinical Assistant Professor at Arizona State University. Prior to this, she was an Instructor at the same institution from 2017 to 2020. Her experience includes roles as a Research Scientist at Texas Tech University Health Science Center and teaching and research positions at Jamia Hamdard and King Abdulaziz University. She also completed postdoctoral fellowships at Augusta University and UT Southwestern Medical Center.👨‍🔬🌍

Awards and Honors 🏆

Dr. Bhatia’s accolades include the 2024 SUN Award for exemplary service in supporting student success, and multiple SUN Awards in 2023 for leadership and social embeddedness. She received a Post-doctoral Fellowship from the American Heart Association in 2012 and has been honored with travel awards and research fellowships from prestigious organizations, reflecting her commitment to advancing scientific knowledge.

Research Interests 🔬

🔬Dr. Bhatia’s research centers on neurodegenerative disorders, with a particular emphasis on the role of the complement system in vascular dysfunction and cognitive impairment. She investigates the molecular mechanisms underlying conditions such as vascular cognitive impairment and stroke, aiming to develop therapeutic strategies that mitigate neuroinflammation and promote neuroprotection.🌿🧪

Conclusion 🔚 

Dr. Kanchan Bhatia’s multifaceted expertise, strong academic track record, and dedication to innovation and student success make her a deserving candidate for the Best Researcher Award. Addressing minor areas of improvement, such as increasing research funding and international collaborations, would further enhance her contributions to the academic and research community.

Publications Top Notes 📚

Complement C3a Receptor (C3aR) Mediates Vascular Dysfunction, Hippocampal Pathology, and Cognitive Impairment in a Mouse Model of VCID

Authors: Bhatia, K., Kindelin, A., Nadeem, M., Ahmad, S., Ducruet, A.F.

Citations: 5

Year: 2022

Remote Ischemic Post-Conditioning Therapy is Protective in Mouse Model of Traumatic Optic Neuropathy

Authors: Nadeem, M., Kindelin, A., Mahady, L., Ducruet, A.F., Ahmad, S.

Citations: 8

Year: 2021

Complement C3a receptor-mediated vascular dysfunction: A complex interplay between aging and neurodegeneration

Authors: Bhatia, K., Ahmad, S., Kindelin, A., Ducruet, A.F.

Citations: 22

Year: 2021

C3a receptor antagonist therapy is protective with or without thrombolysis in murine thromboembolic stroke

Authors: Ahmad, S., Pandya, C., Kindelin, A., Hoda, M.N., Ducruet, A.F.

Citations: 11

Year: 2020

Impact of COVID-19 on the cerebrovascular system and the prevention of RBC lysis

Authors: Akhter, N., Ahmad, S., Alzahrani, F.A., Alharbi, R.A., Sindi, A.A.-A.

Citations: 12

Year: 2020

Acetyl-11-keto-β-boswellic acid (AKBA) Attenuates Oxidative Stress, Inflammation, Complement Activation and Cell Death in Brain Endothelial Cells Following OGD/Reperfusion

Authors: Ahmad, S., Khan, S.A., Kindelin, A., Hoda, M.N., Ducruet, A.F.

Citations: 40

Year: 2019

The Role of Complement C3a Receptor in Stroke

Authors: Ahmad, S., Bhatia, K., Kindelin, A., Ducruet, A.F.

Citations: 17

Year: 2019

C3a receptor inhibition protects brain endothelial cells against oxygen-glucose deprivation/reperfusion

Authors: Ahmad, S., Kindelin, A., Khan, S.A., Bhatia, K., Ducruet, A.F.

Citations: 20

Year: 2019

Combined deficiency of Senataxin and DNA-PKcs causes DNA damage accumulation and neurodegeneration in spinal muscular atrophy

Authors: Kannan, A., Bhatia, K., Branzei, D., Gangwani, L.

Citations: 63

Year: 2018